By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Xencor 

111 West Lemon Avenue

Monrovia  California  91016  U.S.A.
Phone: 626-305-5900 Fax: 626-305-0350


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Discovery





Company News
Xencor To Host Fourth Quarter And Full Year 2016 Financial Results Webcast And Conference Call On February 28, 2017 2/22/2017 11:10:07 AM
Xencor Release: Igg4-Related Disease Biomarker Development Update Presented From An Ongoing, Open-Label, Phase II Study Of Xmab5871 In Igg4-RD At The 3rd International Symposium On Igg4-Related Diseases & Fibrosis 2/20/2017 6:11:43 AM
Xencor Announces Completion Of Public Offering Of Common Stock And Exercise In Full Of Option To Purchase Additional Shares Of Common Stock 12/7/2016 6:47:09 AM
Xencor Prices Public Offering Of Common Stock 12/1/2016 12:48:23 PM
Xencor Announces Proposed Public Offering Of Common Stock 12/1/2016 11:00:31 AM
Selexis SA And Xencor Enter Strategic Agreement, Strengthening Existing Relationship For Multi-Specific Antibody Cell Line Development 11/3/2016 11:29:22 AM
Xencor Reports Third Quarter 2016 Financial Results 11/3/2016 9:20:30 AM
Selexis SA And Xencor Enter Strategic Agreement, Strengthening Existing Relationship For Multi-Specific Antibody Cell Line Development 11/3/2016 9:02:10 AM
Why Biogen (BIIB), bluebird bio (BLUE) and Xencor are 3 Stocks to Look at in November 11/3/2016 6:28:25 AM
Xencor Release: Xenoscope, the Revolutionary Cost-effective Laparoscope, Wins FDA Fast Track Clearance 10/4/2016 8:18:43 AM
12345678910...
//-->